Peter Stevan Jerome, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 E Marshall Ave, Longview, TX 75601 Phone: 903-315-1488 Fax: 903-315-1656 |
News Archive
A novel therapy that would allow doctors to turn the body's blood-clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing angioplasty but was associated with higher rates of moderate to severe bleeding, according to an analysis of data from a terminated Phase III trial presented at the American College of Cardiology's 64th Annual Scientific Session.
A Wyoming Senate committee has voted to advance a bill that would give lawmakers until 2013 to decide whether the state should create its own health care exchange. … A committee of state lawmakers, health-care representatives and members of the public has been trying to determine if it would be cost-effective for Wyoming to form its own exchange and how one would be managed (2/15).
Evidence is mounting that a poor diet plays an important role in the development of age-related macular degeneration, a leading cause of blindness in the United States.
McCormack Innovation, working alongside strategic partners including the University of Dundee to develop the world's first soluble medical dressings that will dissolve in seconds when immersed in water, has signed a significant supply agreement to the Yemen.
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that Teresa H. Evering, M.D., M.S., a co-lead investigator (with Eric S. Daar, M.D.) for BRII-196/BRII-198 in the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies, will present data for the monoclonal antibody combination at the virtual IDWeek 2021 conference, taking place September 29 – October 3, 2021.
› Verified 2 days ago